Basics Neumora Therapeutics, Inc. IPO Date: September 15, 2023 Sector: Healthcare Industry: Biotech Market Cap: $234.53M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.61% Avg Daily Range (30 D): $0.06 | 5.59% Avg Daily Range (90 D): $0.05 | 4.92% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): 1.3M Avg Daily Volume (90 D): .99M Trade Size Avg Trade Size (Sh.): 129 Avg Trade Size (Sh.) (30 D): 230 Avg Trade Size (Sh.) (90 D): 202 Institutional Trades Total Inst.Trades: 288 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.8M Avg Inst. Trade (90 D): $1.64M Avg Inst. Trade Volume: .21M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $5.12M Avg Closing Trade (90 D): $3.06M Avg Closing Volume: 292.74K     News Jul 23, 2025 @ 11:00 AM Neumora Therapeutics to Report Second Quarter 2025... Source: Helen Rubinstein Jul 9, 2025 @ 11:00 AM Neumora Therapeutics Announces Initiation of Phase... Source: Nick Brandon, Ph.D. May 28, 2025 @ 1:45 AM Kuehn Law Encourages Investors of Grocery Outlet H... Source: N/A May 28, 2025 @ 1:40 AM Kuehn Law Encourages Investors of Neumora Therapeu... Source: N/A Apr 6, 2025 @ 1:35 PM Faruqi & Faruqi Reminds Neumora Therapeutics Inves... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.42 $-.45 Diluted EPS $-.42 $-.45 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -67.99M $ -72.55M Operating Income / Loss $ $ -70.94M $ -76.65M Cost of Revenue $ $ $ Net Cash Flow $ $ M $ 125.04M PE Ratio